02 Oct2015
Milestone drug approvals on a single day pave way for new therapies in Japan
With Merck’s diabetes drug approval, Japan becomes the first country to sell MARIZEV, which offers an important option for people in Japan to manage their type 2 diabetes
September 28th witnessed the Japanese Ministry of Health, Labour and Welfare (MHLW) granting approvals to many drugs aimed at treating important medical conditions in Japan.
With Merck’s diabetes drug approval, Japan becomes the first country to sell MARIZEV, which offers an important option for people in Japan to manage their type 2 diabetes, particularly for those who prefer once-weekly dosing.
